Arteris, Inc. (NASDAQ:AIP – Get Free Report) Director Saiyed Atiq Raza sold 2,400 shares of the company’s stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $10.01, for a total value of $24,024.00. Following the sale, the director now owns 843,842 shares of the company’s stock, valued at approximately $8,446,858.42. This trade represents a 0.28 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Arteris Price Performance
Shares of NASDAQ:AIP opened at $10.29 on Friday. The business has a 50 day moving average price of $8.00 and a 200 day moving average price of $7.83. Arteris, Inc. has a twelve month low of $4.83 and a twelve month high of $10.60. The company has a market cap of $413.42 million, a price-to-earnings ratio of -10.72 and a beta of 1.25. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30.
Analyst Upgrades and Downgrades
Separately, Rosenblatt Securities reiterated a “buy” rating and set a $15.00 price target on shares of Arteris in a research note on Wednesday, November 6th.
Institutional Trading of Arteris
Hedge funds have recently added to or reduced their stakes in the business. US Bancorp DE bought a new stake in Arteris during the 3rd quarter valued at approximately $34,000. The Manufacturers Life Insurance Company acquired a new position in Arteris in the 2nd quarter valued at approximately $86,000. Algert Global LLC acquired a new position in Arteris in the 2nd quarter valued at approximately $115,000. MetLife Investment Management LLC raised its holdings in Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after acquiring an additional 9,551 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new position in Arteris in the 3rd quarter valued at approximately $226,000. Institutional investors own 64.36% of the company’s stock.
About Arteris
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Recommended Stories
- Five stocks we like better than Arteris
- Most Volatile Stocks, What Investors Need to Know
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Why Invest in High-Yield Dividend Stocks?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- How to Calculate Stock Profit
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.